Wednesday, May 24, 2023 10:46:04 AM
Astellas buys Iveric Bio for about $5.9 billion for opthalmology treatments.
Takeda bought Nimbus Therapeutics psoriasis unit for $6 billion in December.
Sorrento has at least 5 phase 3 drugs to spin off for multi-billions.
Abivertinib, 2 PD-L1's, Semdexa and Ovydso.
JUST ONE SALE OR PARTNERSHIP IS NEEDED!
"The refusal of the real is the number one dogma of our time" Rene Girard
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM